Related content

Screening for germline DND1 mutations in testicular cancer patients

By Sijmons Rolf   Vos Yvonne   Herkert Johanna   Bos Krista   Holzik Martijn   Hoekstra-Weebers Josette   Hofstra Robert   Hoekstra Harald  

Familial Cancer, Vol. 9, Iss. 3, 2010-09 ,pp. : 439-442

Springer Publishing Company

Access to resources Recommend Favorite

Survival from breast cancer in patients with CHEK2 mutations

By Huzarski T.   Cybulski C.   Wokolorczyk D.   Jakubowska A.   Byrski T.   Gronwald J.   Domagała P.   Szwiec M.   Godlewski D.   Kilar E.   Marczyk E.   Siołek M.   Wiśniowski R.   Janiszewska H.   Surdyka D.   Sibilski R.   Sun P.   Lubiński J.   Narod S.  

Breast Cancer Research and Treatment, Vol. 144, Iss. 2, 2014-04 ,pp. : 397-403

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families

By Slater Emily   Langer Peter   Fendrich Volker   Habbe Nils   Chaloupka Brunhilde   Matthäi Elvira   Sina Mercedes   Hahn Stephan   Bartsch Detlef  

Familial Cancer, Vol. 9, Iss. 3, 2010-09 ,pp. : 335-343

Springer Publishing Company

Access to resources Recommend Favorite

Relationship of BRCA1 and BRCA2 mutations with cancer burden in the family and tumor incidence

By Esteban Cardeñosa Eva   Bolufer Gilabert Pascual   Juan Jiménez Inmaculada   Palanca Suela Sarai   Barragán González Eva   González Anguix Virginia   Lerma Alejos Enrique   Chirivella González Isabel   Segura Huerta Ángel   Guillén Ponce Carmen   Martínez de Dueñas Eduardo   Cuevas Cuerda Dolores   Salas Trejo Dolores  

Familial Cancer, Vol. 9, Iss. 3, 2010-09 ,pp. : 291-295

Springer Publishing Company

Access to resources Recommend Favorite

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

By Neibergs Holly  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 59-60

Informa Healthcare

Access to resources Recommend Favorite